chr14-77139672-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_174976.2(ZDHHC22):āc.67T>Cā(p.Phe23Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000641 in 1,559,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000013 ( 0 hom., cov: 33)
Exomes š: 0.0000057 ( 0 hom. )
Consequence
ZDHHC22
NM_174976.2 missense
NM_174976.2 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 3.98
Genes affected
ZDHHC22 (HGNC:20106): (zinc finger DHHC-type palmitoyltransferase 22) Predicted to enable protein-cysteine S-palmitoyltransferase activity. Involved in protein localization to plasma membrane and protein palmitoylation. Located in Golgi apparatus; endoplasmic reticulum; and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
TMEM63C (HGNC:23787): (transmembrane protein 63C) Enables calcium activated cation channel activity. Involved in cation transport. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. Biomarker of focal segmental glomerulosclerosis. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.17318702).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZDHHC22 | NM_174976.2 | c.67T>C | p.Phe23Leu | missense_variant | 2/3 | ENST00000319374.4 | |
ZDHHC22 | NM_001364172.1 | c.67T>C | p.Phe23Leu | missense_variant | 2/3 | ||
ZDHHC22 | XM_011536661.3 | c.67T>C | p.Phe23Leu | missense_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZDHHC22 | ENST00000319374.4 | c.67T>C | p.Phe23Leu | missense_variant | 2/3 | 1 | NM_174976.2 | P1 | |
ZDHHC22 | ENST00000555389.1 | c.67T>C | p.Phe23Leu | missense_variant | 2/2 | 4 | |||
ZDHHC22 | ENST00000555327.1 | c.67T>C | p.Phe23Leu | missense_variant | 3/3 | 2 | |||
TMEM63C | ENST00000557408.5 | c.-237+22830A>G | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152226Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
2
AN:
152226
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000330 AC: 6AN: 181984Hom.: 0 AF XY: 0.0000307 AC XY: 3AN XY: 97754
GnomAD3 exomes
AF:
AC:
6
AN:
181984
Hom.:
AF XY:
AC XY:
3
AN XY:
97754
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000569 AC: 8AN: 1406936Hom.: 0 Cov.: 32 AF XY: 0.00000577 AC XY: 4AN XY: 693822
GnomAD4 exome
AF:
AC:
8
AN:
1406936
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
693822
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152226Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74366
GnomAD4 genome
AF:
AC:
2
AN:
152226
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 16, 2023 | The c.67T>C (p.F23L) alteration is located in exon 2 (coding exon 1) of the ZDHHC22 gene. This alteration results from a T to C substitution at nucleotide position 67, causing the phenylalanine (F) at amino acid position 23 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;D;D
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;.;.
Polyphen
B;.;.
Vest4
MutPred
Gain of catalytic residue at F23 (P = 0.1533);Gain of catalytic residue at F23 (P = 0.1533);Gain of catalytic residue at F23 (P = 0.1533);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at